Stocks --- The
Trader: The Rally May Pause, but Not Expire
Barron's
(c) 2006 Dow Jones &
Company, Inc.
***
The prevailing take on the stock-options back-dating kerfuffle
casts the granting of winning lottery tickets to insiders as a
youthful indulgence by corporate boards caught up in the manic peer
pressure of the bubble years. By this formulation, the post-Enron
Sarbanes-Oxley regulations imposed maturity on chastened directors
and executives, and indeed most of the admitted inquiries into
suspicious propitious options grants have focused on the years
before Sarbox emerged in 2003.
But a research group that specializes in scouring the fine print
has come up with persuasive evidence that plenty of companies
followed questionable patterns of option grants long after the
supposed Sarbox reforms took hold.
Glass Lewis, in a study to be released this week, tracked the
regulatory filings in which companies disclose option grants. Sarbox
mandated that companies report option awards to the SEC within two
days of the grants in so-called Form 4 filings. Lots of companies
routinely miss the deadline, with rare enforcement action by
regulators. Glass Lewis makes the case that filing Form 4s late and
dating an options grant in the past when the stock price was much
lower in itself can be suspicious.
Looking only at filings that arrived at least two weeks late --
and many of them were six months or more late -- Glass Lewis
concluded that numerous companies not yet implicated in the
back-dating flap should be scrutinized. The universe of late filers,
covering thousands of individual option grants, saw their stocks
rise an average of 6% from the stated grant date to the filing date,
outpacing the Russell 3000's 4.4% gain in the relevant period.
Glass Lewis names nine companies whose grants seem suspicious
under this light. Children's Place Retail Stores (PLCE), Hansen
Natural (HANS), O'Reilly Automotive (ORLY), Digital River (DRIV),
American Home Mortgage Investment (AHM), Websense (WBSN), Silicon
Image (SIMG), Keryx Biopharmaceuticals (KERX) and Medis Technologies
(MDTL) are on the list.
All either denied wrongdoing or couldn't be reached when Glass
Lewis asked about the patterns. In each case, the tardy filings
disclose grants dated to a day when the companies' share prices were
appreciably lower.
This analysis is less a smoking gun than a
where-there's-smoke-there-might-be-fire exercise. Still, it strongly
suggests that if there was a moment when companies got scrupulous
about the dating of option grants, it wasn't when Congress passed a
new corporate-governance law, but when the Wall Street Journal
exposed the irregularities last spring.
***
---
E-mail: michael.santoli@barrons.com
---
For Barron's subscription information call 1-888-BARRONS ext. 685
or inquire online at http://www.barronsmag.com/subscription/subscription.html
[http://www.barronsmag.com/subscription/subscription.html].